EDX
EDX Medical Group Plc
Access
ISIN
GB00BNDMJS47
Bid
2.60
Mid
2.70
Ask
2.80
Key Information
- Price Change
- 0.00%
- Year High
- 5.38
- Year Low
- 2.70
- Last Trade
- 24 Mar 23
- Market Cap
- 6.818M
- Par
- 0.01
- Bid
- 2.60
- Mid Price
- 2.70
- Ask
- 2.80
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 252.5M
- Sector
- Healthcare
About EDX Medical Group Plc
EDX Medical develops and delivers innovative digital diagnostic products and services for cancer, heart disease, neurology and infectious disease testing, helping to predict disease risk, inform clinical decision-making and accelerate the development of new medicines. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection of disease risk and personalise disease management in a timely fashion. Early disease detection and risk prediction is the most impactful way of reducing deaths and lowering the future costs of healthcare provision globally. EDX Medical operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development (R&D), provides testing and genomic sequencing services, undertakes quality assurance and has established expertise in the design, development, validation and sourcing of diagnostic tests at commercial scale. Key tests performed in this laboratory have been audited by the United Kingdom Accreditation Service (UKAS) and accredited to ISO 15189.
Latest Trades
Date | Volume | Price | Value |
---|---|---|---|
23 Mar 23 14:38 | 17,000 | 2.8 | 47,600 |
23 Mar 23 13:45 | 20,000 | 3 | 60,000 |
23 Mar 23 13:45 | 20,000 | 3 | 60,000 |
23 Mar 23 13:45 | 25,000 | 3 | 75,000 |
10 Mar 23 13:26 | 400,000 | 3.02 | 1,208,000 |
Latest Announcements
Date | Title |
---|---|
13 Mar 23 07:00 | EDX Medical Group Plc - Director Dealing |
01 Mar 23 11:33 | EDX Medical Group Plc - Total Voting Rights Correction |
17 Feb 23 07:00 | EDX Medical Group Plc - Acquisition of Torax Biosciences |
20 Dec 22 07:00 | EDX Medical Group Plc - Interim Report for the six-months to 30 September 2022 |
21 Nov 22 07:00 | EDX Medical Group Plc - Collaboration Programme with Tianjin Bioscience |
Address
Registered Address
Unit 210-211 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA, United KingdomPhone
Contacts
Corporate Adviser
Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, EC2V 6EE, United KingdomRegistrar
Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom